ConductScience.org, home

Paper41002441

Next-Generation mRNA Vaccines in Melanoma: Advances in Delivery and Combination Strategies.

Zoroddu S and 1 other. Cells, 2025. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Next-Generation mRNA Vaccines in Melanoma: Advances in Delivery and Combination Strategies. Papers, record 41002441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41002441

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Next-Generation mRNA Vaccines in Melanoma: Advances in Delivery and Combination Strategies.
PubMed
Journal
Cells
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
3.71, provisional
iCite
Revised in PubMed
2025-09-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zoroddu SStefanohttps://orcid.org/0000-0003-4423-9745
2Bagella LLuigihttps://orcid.org/0000-0003-2815-037X

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
Cancer VaccinesMajor topic
mRNA VaccinesMajor topic
RNA, MessengerMajor topic
Humans
Immunotherapy
Animals

Source PubMed

Download CSV of topics

References84

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138282471Recent progress in mRNA cancer vaccines.Hum Vaccin Immunother2024https://conductscience.org/library/papers/38282471PubMed
241002395mRNA Multipeptide-HLA Class II Immunotherapy for Melanoma.Cells2025https://conductscience.org/library/papers/41002395PubMed
339827147Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges.Mol Cancer2025https://conductscience.org/library/papers/39827147PubMed
437339211Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/37339211PubMed
537414361mRNA: A promising platform for cancer immunotherapy.Adv Drug Deliv Rev2023https://conductscience.org/library/papers/37414361PubMed
639256822Current landscape of mRNA technologies and delivery systems for new modality therapeutics.J Biomed Sci2024https://conductscience.org/library/papers/39256822PubMed
740456769Multi-omics and AI-driven immune subtyping to optimize neoantigen-based vaccines for colorectal cancer.Sci Rep2025https://conductscience.org/library/papers/40456769PubMed
839290693Local administration of mRNA encoding cytokine cocktail confers potent anti-tumor immunity.Front Immunol2024https://conductscience.org/library/papers/39290693PubMed
929664013β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas.J Clin Invest2018https://conductscience.org/library/papers/29664013PubMed
1038086815Therapeutic cancer vaccines: advancements, challenges, and prospects.Signal Transduct Target Ther2023https://conductscience.org/library/papers/38086815PubMed
1138890171Expression of the tumor antigens NY-ESO-1, tyrosinase, MAGE-A3, and TPTE in pediatric and adult melanoma: a retrospective case control study.Virchows Arch2024https://conductscience.org/library/papers/38890171PubMed
1238238340Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact.NPJ Vaccines2024https://conductscience.org/library/papers/38238340PubMed
1339798545Clinical advances of mRNA vaccines for cancer immunotherapy.Med2025https://conductscience.org/library/papers/39798545PubMed
1438239240Advanced nano-based strategies for mRNA tumor vaccine.Acta Pharm Sin B2024https://conductscience.org/library/papers/38239240PubMed
1539590584Advances in mRNA LNP-Based Cancer Vaccines: Mechanisms, Formulation Aspects, Challenges, and Future Directions.J Pers Med2024https://conductscience.org/library/papers/39590584PubMed
1630388456Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.Cell2018https://conductscience.org/library/papers/30388456PubMed
1738582088Unlocking the power of nanomedicine: Cell membrane-derived biomimetic cancer nanovaccines for cancer treatment.Med2024https://conductscience.org/library/papers/38582088PubMed
1837744371Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities.Front Immunol2023https://conductscience.org/library/papers/37744371PubMed
1938242890Development and use of machine learning algorithms in vaccine target selection.NPJ Vaccines2024https://conductscience.org/library/papers/38242890PubMed
2037511023RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines.Int J Mol Sci2023https://conductscience.org/library/papers/37511023PubMed

See all 84 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42898919miRNAs bridging the gap between the tumor microenvironment and liquid biopsy in cutaneous melanoma.Front Immunol2026https://conductscience.org/library/papers/42898919PubMed
42794593Personalized mRNA Neoantigen Vaccines in Cancer: Linking Precision Antigen Selection, Immune Remodeling, and Checkpoint Blockade.Int J Mol Sci2026https://conductscience.org/library/papers/42794593PubMed
42724148Therapeutic melanoma vaccines: Platforms, neoantigen strategies, and emerging combination immunotherapies.Ther Adv Vaccines Immunother2026https://conductscience.org/library/papers/42724148PubMed
42651807Engineering the Future of Precision Medicine: A Comprehensive Guide to RNA Therapeutics.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42651807PubMed
42646699Advances in Therapeutic Melanoma Vaccines (2010-2025).Vaccines (Basel)2026https://conductscience.org/library/papers/42646699PubMed
42614300From pathogen defence to precision health infrastructure: mRNA vaccines beyond infectious disease in preventive health, chronic disease management, and population wellbeing.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42614300PubMed
42565117Beyond the genetic code: orchestrating epigenetic and immune landscapes with multivalent mRNA-exosome vaccines.Precis Clin Med2026https://conductscience.org/library/papers/42565117PubMed
42482783mRNA cancer vaccines: delivery strategies, immune modulation, and clinical translation.Front Pharmacol2026https://conductscience.org/library/papers/42482783PubMed
42350438Next-generation mRNA vaccines: strategies to overcome stability challenges.NPJ Vaccines2026https://conductscience.org/library/papers/42350438PubMed
42344914From Jenner to genomics: the unfolding future of vaccinology.Front Immunol2026https://conductscience.org/library/papers/42344914PubMed
42162504Integrating multi-omics data for next-generation cancer research and precision medicine.Clin Transl Oncol2026https://conductscience.org/library/papers/42162504PubMed
41934551mRNA-based melanoma vaccines targeting gp100 and TRP2 macromolecules.Discov Oncol2026https://conductscience.org/library/papers/41934551PubMed
41834982[Clinical Progress and Prospects of mRNA Tumor Drugs].Sichuan Da Xue Xue Bao Yi Xue Ban2026https://conductscience.org/library/papers/41834982PubMed
41800027Tumor Cells as Architects of Immune Refractoriness: Dismantling Intrinsic Programs of Tumor Cells for Clinical Translation.Immune Netw2026https://conductscience.org/library/papers/41800027PubMed
41677661mRNA Vaccines in Melanoma Immunotherapy-A Narrative Review.Cells2026https://conductscience.org/library/papers/41677661PubMed
41597174Advances in mRNA-Based Melanoma Vaccines: A Narrative Review of Lipid Nanoparticle and Dendritic Cell Delivery Platforms.Cells2026https://conductscience.org/library/papers/41597174PubMed
41302945
Pathway-Specific Therapeutic Modulation of Melanoma: Small-Molecule Inhibition of BRAF-MEK and KIT Signaling in Contemporary Precision Oncology with a Special Focus on Vemurafenib, Trametinib, and Imatinib.
J Clin Med2025https://conductscience.org/library/papers/41302945PubMed

Download CSV of cited by

Genes18

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CAP110487PubTator's text mininghttps://conductscience.org/library/genes/10487NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTAG1A246100PubTator's text mininghttps://conductscience.org/library/genes/246100NCBI Gene
HBA23040PubTator's text mininghttps://conductscience.org/library/genes/3040NCBI Gene
HBB3043PubTator's text mininghttps://conductscience.org/library/genes/3043NCBI Gene
IFIH164135PubTator's text mininghttps://conductscience.org/library/genes/64135NCBI Gene
IL12B3593PubTator's text mininghttps://conductscience.org/library/genes/3593NCBI Gene
IL73574PubTator's text mininghttps://conductscience.org/library/genes/3574NCBI Gene
MAGEA34102PubTator's text mininghttps://conductscience.org/library/genes/4102NCBI Gene
MLANA2315PubTator's text mininghttps://conductscience.org/library/genes/2315NCBI Gene
NF14763PubTator's text mininghttps://conductscience.org/library/genes/4763NCBI Gene
NRAS4893PubTator's text mininghttps://conductscience.org/library/genes/4893NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene
RIGI23586PubTator's text mininghttps://conductscience.org/library/genes/23586NCBI Gene
TPTE7179PubTator's text mininghttps://conductscience.org/library/genes/7179NCBI Gene
TYR7299PubTator's text mininghttps://conductscience.org/library/genes/7299NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41002441

GET https://conductscience.org/api/papers/v1/41002441/references?page=2